Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Atypical MOLes and Melanoma Early Detection Study (MoleMed) (MoleMed)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04353050
Recruitment Status : Recruiting
First Posted : April 20, 2020
Last Update Posted : July 20, 2021
Sponsor:
Collaborator:
Blokhin's Russian Cancer Research Center
Information provided by (Responsible Party):
Igor Samoylenko, Blokhin's Russian Cancer Research Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 1, 2022
Estimated Study Completion Date : November 1, 2022